GermanyDeutsche Welle fact-checked claims that statins, which are widely used cholesterol-lowering drugs, cause dementia. These claims, often spread by social media influencers, suggest that statins lead to cognitive decline or memory issues. However, a major review of medical research conducted by the Cholesterol Treatment Trialists' Collaboration, published in The Lancet, found no evidence that statins increase the risk of dementia or cognitive impairment. This review analyzed data from over 123,000 participants across multiple clinical trials and concluded that there was no significant difference in cognitive outcomes between those taking statins and those receiving a placebo. Additional systematic reviews and meta-analyses reached the same conclusion, reinforcing that statins do not raise dementia risk. Some experts even suggest that statins might offer protective benefits against certain forms of dementia.
Bias read (Center): The article presents a balanced view of the scientific consensus regarding statins and dementia, citing multiple studies and expert opinions without showing favoritism toward any side. It clearly distinguishes between misinformation spread online and the findings of credible medical research.
